Literature DB >> 19490175

Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome.

E Espinosa1, A Peña-Jiménez, C E Ormsby, R Vega-Barrientos, G Reyes-Terán.   

Abstract

OBJECTIVES: The aim of the study was to determine whether immune reconstitution inflammatory syndrome (IRIS) associated with herpes zoster occurs on a different time frame from other instances of IRIS.
METHODS: Statistical analysis of onset times of herpes zoster-associated IRIS and other cases of IRIS was carried out in a retrospective cohort starting antiretroviral therapy at advanced stages of HIV infection.
RESULTS: Herpes zoster-associated IRIS was significantly more frequent after the first 3 months of successful highly active antiretroviral therapy (HAART), than other instances of IRIS (IRIS associated with tuberculosis, Mycobacterium avium complex, Kaposi's sarcoma, etc.) which mainly occurred during the first 3 months of treatment.
CONCLUSIONS: The characteristic onset time pattern of herpes zoster-associated IRIS, coincident with the second phase of immune recovery under HAART, suggests that the immune recovery events underlying herpes zoster-associated IRIS are different from those underlying other types of IRIS. Our findings may be useful in improving the follow-up of individuals who start HAART at an advanced stage of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490175     DOI: 10.1111/j.1468-1293.2009.00700.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  6 in total

Review 1.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 2.  Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS).

Authors:  Micheline McCarthy; Avindra Nath
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 6.030

3.  Ramsay Hunt syndrome in a patient with human immunodeficiency virus infection.

Authors:  Mrinal Gupta
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jan-Jun

4.  Herpes zoster in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Authors:  Masataka Taoka; Nobuaki Ochi; Hiromichi Yamane; Takenobu Yamamoto; Tatsuyuki Kawahara; Emiko Uji; Youko Kosaka; Kouhei Takeda; Yasunari Nagasaki; Hidekazu Nakanishi; Yumi Aoyama; Nagio Takigawa
Journal:  Transl Cancer Res       Date:  2022-03       Impact factor: 1.241

5.  Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.

Authors:  Lewis John Haddow; Mahomed-Yunus Suleman Moosa; Anisa Mosam; Pravi Moodley; Raveen Parboosing; Philippa Jane Easterbrook
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

6.  Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.

Authors:  Chenglong Liu; Cuiwei Wang; Marshall J Glesby; Gypsyamber D'souza; Audrey French; Howard Minkoff; Toby Maurer; Roksana Karim; Mary Young
Journal:  AIDS Res Ther       Date:  2013-12-27       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.